lorazepam (Q408265)

Institute for Safe Medication Practices

LORazepam

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

chemical formula

C₁₅H₁₀Cl₂N₂O₂

1 reference

lorazepam (English)

19 November 2016

C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl

1 reference

lorazepam (English)

19 November 2016

2.5 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05BA06

2.5 milligram

route of administration

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05BA06

1 reference

14 February 2018

World Health Organisation international non-proprietary name

lorazepam (English)

1 reference

1 reference

Occurrence of "natural" benzodiazepines

Triticum aestivum

1 reference

Occurrence of "natural" benzodiazepines

medical condition treated

1 reference

schizophreniform disorder

13 December 2016

1 reference

13 December 2016

2 references

13 December 2016

2 October 2018

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

2 October 2018

sleep-wake disorder

1 reference

2 October 2018

anxiety

1 reference

significant drug interaction

2 October 2018

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mirtazapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Alpha-1B adrenergic receptor

subject has role

allosteric modulator

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

G protein-coupled receptor 68

17 August 2016

subject has role

allosteric modulator

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

English Wikipedia

US pregnancy category D

1 reference

LiverTox likelihood score

English Wikipedia

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Lorazepam

24 January 2017

1 reference

https://www.pfizer.com/products/product-list

mass

320.011933 dalton

1 reference

GABAA receptor positive allosteric modulators

lorazepam (English)

4 October 2016

0 references

1 reference

5 March 2018

1 reference

15 March 2018

1 reference

MeSH descriptor ID

D008140

15 March 2018

hypnotics and sedatives

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

MeSH descriptor ID

D008140

15 March 2018

developmental toxicant

start time

1 July 1990

1 reference

California Proposition 65 list of chemicals

17 March 2020

https://oehha.ca.gov/chemicals/lorazepam

essential medicine

0 references

MCN code

2933.91.42

0 references

different from

loprazolam

1 reference

https://en.wikipedia.org/w/index.php?title=Lorazepam&oldid=950655103

English Wikipedia

Wikimedia import URL

Commons category

Lorazepam

0 references

Identifiers

National Library of Israel J9U ID

987007536155105171

0 references

Library of Congress authority ID

sh85078346

0 references

InChI

InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)

1 reference

lorazepam (English)

19 November 2016

2 references

lorazepam (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

846-49-1

2 references

lorazepam (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=846-49-1

8 April 2021

1 reference

Lorazepam (English)

19 November 2016

2 references

lorazepam (English)

19 November 2016

ChEBI ID

6539

mapping relation type

exact match

2 references

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)

1 reference

LORAZEPAM (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU151206

1 reference

MassBank accession ID

SM860002

0 references

SM860053

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003513

0 references

MSBNK-Waters-WA001043

0 references

MSBNK-Waters-WA001044

0 references

MSBNK-Waters-WA001045

0 references

MSBNK-Waters-WA001046

0 references

MSBNK-Waters-WA001047

0 references

MSBNK-Waters-WA001048

0 references

MSBNK-Waters-WA001049

0 references

SPLASH

splash10-00di-0009000000-53bbea620bd1e8b49eb3

0 references

splash10-0fb9-0095000000-793565a97e3afc2ce858

0 references

splash10-004i-0090000000-41097b8a64363c5e2f94

0 references

splash10-004i-0290000000-a0694111a3943eca2b53

0 references

splash10-004i-0690000000-5a4728cb7e2473fc6b3c

0 references

splash10-01rf-0940000000-39d041fbab4fb67a5c41

0 references

splash10-001i-0091000000-04730f82e569df7febdd

0 references

splash10-001i-0390000000-dd63d93f2fa81cbb5928

0 references

splash10-0udi-0930000000-3ecf1f2f10049a3cfee2

0 references

splash10-0udi-0910000000-95d23a9a121bf45ef8bf

0 references

splash10-0udi-0900000000-cdbe26e697f259770c28

0 references

splash10-0udi-0900000000-4046d54b4dd9bf7968be

0 references

splash10-009i-6791000000-942b7493f1e9fc3d12be

0 references

splash10-00b9-0196000000-2e53b39b27c66ec73fd2

0 references

splash10-001i-0091000000-abaf38ed3aa6e7d51245

0 references

splash10-002r-4981000000-a567f7beb26ee18d061c

0 references

DSSTox substance ID

DTXSID7023225

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

lorazepam (English)

ECHA Substance Infocard ID

19 November 2016

100.011.534

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Lorazepam (English)

CAS no.: 846-49-1 (English)

1 reference

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

D03.633.100.079.080.070.450

lorazepam (English)

19 November 2016

Lorazepam

0 references

MeSH tree code

0 references

1 reference

lorazepam (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014332

2 references

based on heuristic

inferred from InChIKey

2 references

lorazepam (English)

19 November 2016

MedlinePlus drug identifier

a682053

0 references

PatientsLikeMe treatment ID

0 references

1 reference

California Proposition 65 list of chemicals

lorazepam (English)

19 November 2016

0 references

1 reference

1 reference

1 reference

6 January 2020

https://oehha.ca.gov/chemicals/lorazepam

DeCS ID

8316

0 references

electronic Essential Medicines List medicine ID

0 references

1 reference

28 October 2013

Microsoft Academic ID (discontinued)

0 references

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UK Parliament thesaurus ID

346636

subject named as

Lorazepam

0 references

UMLS CUI

C0024002

1 reference

lorazepam (English)

19 November 2016

0 references

0 references

WordNet 3.1 Synset ID

03695331-n

1 reference